2‐Oxoquinoline‐based‐thiosemicarbazones as multitargeting neurotherapeutics against Alzheimer's disease: In vitro and in silico studies of MAO and ChE inhibitors

Rabia Basri, Zahid Shafiq, Asad Syed et al.|Archiv der Pharmazie|2023

Cited by 3